Log in

Relevant bibliographies by topics / D 3.5 UL 2009 F778

Contents

Journal articles

Academic literature on the topic 'D 3.5 UL 2009 F778'

Author: Grafiati

Published: 4 June 2021

Last updated: 13 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'D 3.5 UL 2009 F778.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "D 3.5 UL 2009 F778"

1

Newman, Jill C., Angela M. Malek, Kelly J. Hunt, and Bernadette P. Marriott. "Nutrients in the US Diet: Naturally Occurring or Enriched/Fortified Food and Beverage Sources, Plus Dietary Supplements: NHANES 2009–2012." Journal of Nutrition 149, no. 8 (2019): 1404–12. http://dx.doi.org/10.1093/jn/nxz066.

Full text

Abstract:

ABSTRACT Background Nutrients are added to the diet through fortification/enrichment and dietary supplements (DSs). Meeting the US Dietary Reference Intakes (DRIs) varies by nutrient and population subsegments. Objective The aim of this study was to assess the relative role of naturally occurring, enriched/fortified, and DS sources of 15 micronutrients with reference to the DRIs. Methods We used the NHANES 2009–2012 (≥2 y old, n = 16,975) data, the ILSI North America Fortification database, and the National Cancer Institute usual intake method. Results Prevalence of nutrient intake from natura

APA, Harvard, Vancouver, ISO, and other styles

2

Gaziev, Javid, Antonella Isgro, Katia Paciaroni, et al. "Outcomes of Unrelated Bone Marrow Transplantation in Patients with Thalassemia." Blood 132, Supplement 1 (2018): 5777. http://dx.doi.org/10.1182/blood-2018-99-109764.

Full text

Abstract:

Abstract Introduction. Bone marrow transplantation from an HLA-matched related or unrelated donor remains the only curative treatment for patients with thalassemia. Although one third of patients with thalassemia can find a matched unrelated donor (MUD) few patients were treated by MUD transplantation. Early experience with the use of MUD transplant in class 3 patients with thalassemia resulted in high rates of graft rejection and transplant-related mortality with thalassemia-free (TFS) survival of 53% (La Nasa G et al. Blood 2002). Significant improvements in MUD transplantation in recent yea

APA, Harvard, Vancouver, ISO, and other styles

3

Advani, Anjali S., Shannon McDonough, Edward Copelan, et al. "SWOG S0919: A phase II study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukemia (AML)." Journal of Clinical Oncology 31, no. 15_suppl (2013): 7028. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.7028.

Full text

Abstract:

7028 Background: Inhibition of cholesterol synthesis and uptake sensitizes AML blasts to chemotherapy (Blood 104: 1816, 2004). A prior Phase 1 study demonstrated the safety of high dose pravastatin given with idarubicin and cytarabine in patients with AML and also reported an encouraging response rate (Blood 109: 2999, 2007). SWOG S0919 therefore evaluated the complete remission (CR) rate in a larger number of pts with relapsed AML treated with the pravastatin dose arrived at in the Phase 1 trial. Methods: Pts were treated at SWOG institutions from Aug 2009 through Nov 2012. Pravastatin was su

APA, Harvard, Vancouver, ISO, and other styles

4

Andreeff, Michael, Zhihong Zeng, Mary A. Kelly, et al. "Targeting microenvironment-mediated resistance in leukemias: Phase I trial of mobilization and elimination of FLT3-ITD+ acute myelogenous leukemia (AML) stem/progenitor cells by plerixafor/g-CSF/sorafenib." Journal of Clinical Oncology 30, no. 15_suppl (2012): TPS6635. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.tps6635.

Full text

Abstract:

TPS6635 Background: FLT3-ITD AML are associated with poor prognosis. We identified Sorafenib (S) as potent inhibitor of FLT3-ITD (Zhang W, JNCI, 2008; Borthakur G., Haematologica, 2010). FLT3-ITD is associated with overexpression of chemokine receptor CXCR4 and we found increased in vivo activity of S combined with CXCR4 inhibitor Plerixafor (P) and G-CSF (G) (Zeng Z et.al. Blood 2009). Here we report first data testing this concept in patients with R/R FLT3-ITD AML. Methods: G (10 ug/kg) and P(240 ug/kg) were given s.c. QOD on days 1 – 13, S (400-600mg), S on d 1 - 28(one cycle). G/P was held

APA, Harvard, Vancouver, ISO, and other styles

5

Singh, Prabhsimranjot, Sudhamshi Toom, Makardhwaj S. Shrivastava, and William B. Solomon. "A Rare Combination of Genetic Mutations in an Elderly Female: A Diagnostic Dilemma!" Blood 128, no. 22 (2016): 5487. http://dx.doi.org/10.1182/blood.v128.22.5487.5487.

Full text

Abstract:

Introduction: JAK2 is located on chromosome 9p24 and includes 25 exons encoding a protein of about 1132 amino acids. JAK2 is one of the four Janus family non-receptor protein tyrosine kinases. JAK2V617F is by far the most prevalent mutation in BCR-ABL1-negative Myeloproliferative neoplasms (occurs in ∼95% of patients with polycythemia vera, in ∼55% with essential thrombocythemia and in ∼65% with primary myelofibrosis) 1, 2. More than 80% of hemochromatosis patients are homozygous for a C282Y mutation in HFE gene, and a smaller proportion are compound heterozygous for both the C282Y mutation an

APA, Harvard, Vancouver, ISO, and other styles

6

Andreeff, Michael, Zhihong Zeng, Mary A. Kelly, et al. "Mobilization and Elimination of FLT3-ITD+ Acute Myelogenous Leukemia (AML) Stem/Progenitor Cells by Plerixafor/G-CSF/Sorafenib: Results From a Phase I Trial in Relapsed/Refractory AML Patients." Blood 120, no. 21 (2012): 142. http://dx.doi.org/10.1182/blood.v120.21.142.142.

Full text

Abstract:

Abstract Abstract 142 FLT3-ITD AML are associated with poor prognosis. Our group identified Sorafenib (S) as potent inhibitor of FLT3-ITD (Zhang W, JNCI, 2008; Borthakur G., Haematologica, 2010). FLT3-ITD is also associated with overexpression of the chemokine receptor CXCR4. Utilizing preclinical in vitro and in vivo models we determined increased activity of S when combined with CXCR4 inhibitor Plerixafor (P) and G-CSF (G) (Zeng Z et.al. Blood 2009). Here we report clinical and translational data testing this concept in patients with R/R FLT3-ITD AML. Clinical trial: G (10 ug/kg) and P(240 u

APA, Harvard, Vancouver, ISO, and other styles

7

Advani, Anjali S., Holly Gundacker, Marilyn L. Slovak, et al. "Outcome and Prevalence of Hyperdiploidy and Hypodiploidy in Adults with Newly Diagnosed Acute Lymphocytic Leukemia: A SWOG Study." Blood 118, no. 21 (2011): 2555. http://dx.doi.org/10.1182/blood.v118.21.2555.2555.

Full text

Abstract:

Abstract Abstract 2555 High hyperdiploidy is present in 30% of children with acute lymphocytic leukemia (ALL), and is associated with a favorable prognosis. We evaluated pts with newly diagnosed ALL treated on SWOG trials S9400 (1995–2000) and S0333 (2005–2010) to determine the prevalence and prognostic impact of hyperdiploidy in adults with ALL. Additionally, we examined the prognostic impact of hypodiploidy, a feature typically associated with a poor prognosis in children. Methods: One-hundred and eighty-five pts treated on S9400 and S0333 with successful cytogenetic (CG) analysis were inclu

APA, Harvard, Vancouver, ISO, and other styles

8

Fujimura, Yoshihiro, Yumi Yoshii, Masanori Matsumoto, et al. "A Long-Term Phenotype Analysis Of 51 Patients With Upshaw–Schulman Syndrome In Japan, With Special References To Pregnancy and Renal Failure That Requires Hemodialysis." Blood 122, no. 21 (2013): 3545. http://dx.doi.org/10.1182/blood.v122.21.3545.3545.

Full text

Abstract:

Abstract Backgrounds and Aims The classic hallmarks of Upshaw Schulman syndrome (USS) are severe newborn jaundice with a negative Coombs test that requires an exchange transfusion and repeated childhood episodes of thrombocytopenia and microangiopathic hemolytic anemia that are reversed by infusions of fresh frozen plasma. But now, it is well established that USS is a hereditary deficiency in the activity of von Willebrand factor (VWF)-cleaving protease, termed ADAMTS13. The inheritance mode is autosomal recessive, and their parents are usually asymptomatic carriers having one disease-causing

APA, Harvard, Vancouver, ISO, and other styles

9

Childhood Studies, Journal of. "Call for Papers - Innovative Professional Learning in Early Childhood Education and Care: Inspiring Hope and Action." Journal of Childhood Studies 41, no. 3 (2016). http://dx.doi.org/10.18357/jcs.v41i3.16399.

Full text

Abstract:

<p><strong>Guest editors: Joanne Lehrer (Université du Québec en Outaouais), Christine Massing (University of Regina), Scott Hughes (Mount Royal University), and Alaina Roach O’Keefe (University of Prince Edward Island)</strong></p><p>Not only is professional learning conceptualised as critical for increasing educational quality and enhancing children’s learning and developmental outcomes (e.g. Lazarri et al., 2013; Munton et al., 2002; Penn, 2009; Vandenbroeck et al., 2016), but specific elements of professional learning (in both initial and continuing education,

APA, Harvard, Vancouver, ISO, and other styles

10

Childhood Studies, Journal of. "Call for Papers - Innovative Professional Learning in Early Childhood Education and Care: Inspiring Hope and Action." Journal of Childhood Studies 42, no. 1 (2017). http://dx.doi.org/10.18357/jcs.v42i1.16889.

Full text

Abstract:

<table id="announcementDescription" width="100%"><tbody><tr><td><p><strong>Guest editors: Joanne Lehrer (Université du Québec en Outaouais), Christine Massing (University of Regina), Scott Hughes (Mount Royal University), and Alaina Roach O’Keefe (University of Prince Edward Island)</strong></p><p>Not only is professional learning conceptualised as critical for increasing educational quality and enhancing children’s learning and developmental outcomes (e.g. Lazarri et al., 2013; Munton et al., 2002; Penn, 2009; Vandenbroeck et al., 2016), b

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!